TrialPLoS medicine2021

Applicability and cost-effectiveness of the Systolic Blood Pressure Intervention Trial (SPRINT) in the Chinese population: A cost-effectiveness modeling study.

Chao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.